Abstract
Primary cilia are microtubule-based organelles that extend from the apical surface of most mammalian cells, forming when the basal body (derived from the mother centriole) docks at the apical cell membrane. They act as universal cellular “antennae” in vertebrates that receive and integrate mechanical and chemical signals from the extracellular environment, serving diverse roles in chemo-, mechano- and photo-sensation that control developmental signaling, cell polarity and cell proliferation. Mutations in ciliary genes cause a major group of inherited developmental disorders called ciliopathies. There are very few preventative treatments or new therapeutic interventions that modify disease progression or the long-term outlook of patients with these conditions. Recent work has identified at least four distinct but interrelated cellular processes that regulate cilia formation and maintenance, comprising the cell cycle, cellular proteostasis, signaling pathways and structural influences of the actin cytoskeleton. The actin cytoskeleton is composed of microfilaments that are formed from filamentous (F) polymers of globular G-actin subunits. Actin filaments are organized into bundles and networks, and are attached to the cell membrane, by diverse cross-linking proteins. During cell migration, actin filament bundles form either radially at the leading edge or as axial stress fibers. Early studies demonstrated that loss-of-function mutations in ciliopathy genes increased stress fiber formation and impaired ciliogenesis whereas pharmacological inhibition of actin polymerization promoted ciliogenesis. These studies suggest that polymerization of the actin cytoskeleton, F-actin branching and the formation of stress fibers all inhibit primary cilium formation, whereas depolymerization or depletion of actin enhance ciliogenesis. Here, we review the mechanistic basis for these effects on ciliogenesis, which comprise several cellular processes acting in concert at different timescales. Actin polymerization is both a physical barrier to both cilia-targeted vesicle transport and to the membrane remodeling required for ciliogenesis. In contrast, actin may cause cilia loss by localizing disassembly factors at the ciliary base, and F-actin branching may itself activate the YAP/TAZ pathway to promote cilia disassembly. The fundamental role of actin polymerization in the control of ciliogenesis may present potential new targets for disease-modifying therapeutic approaches in treating ciliopathies.
Introduction
Primary cilia are microtubule-based organelles that extend from the apical surface of the majority of mammalian cells (Figure 1). Cilia act as “cellular antennae” in vertebrates, receiving diverse inputs from the extracellular environment and transducing signals in response. These signal inputs vary but include mechanical stimuli, for example urine fluid shear stress in kidney epithelial cells (Schwartz et al., 1997); proteins, such as those of the Sonic Hedgehog (Shh) pathway (); and low molecular weight chemicals such as dopamine (). The specialized cilium of the photoreceptor, the retinal outer segment, is also capable of sensing and transducing signals in response to light (Molday and Moritz, 2015). Cilia responses contribute to the control of developmental signaling and cell proliferation, as well as the establishment of cell polarity (Ross et al., 2005).
FIGURE 1
Mutations in ciliary genes cause a group of inherited Mendelian developmental disorders termed ciliopathies. Ciliopathies are individually rare but collectively common, affecting up to 1 in 725 people (Wheway et al., 2019). These heterogeneous conditions include kidney diseases, blinding disorders, obesity associated diseases, severe neurodevelopmental abnormalities and skeletal dysplasias [reviewed in Tobin and Beales (2009) and Waters and Beales (2011)]. Ciliopathies can result from defects in the organization or function of the main ciliary components such as the basal body or transition zone, or can be due to deficits in the trafficking of ciliary axoneme components or the transcriptional regulation of ciliogenesis (Reiter and Leroux, 2017).
Treatment options for ciliopathies have been limited to date and have focused on alleviating symptoms rather than treating the causes. Although antisense oligonucleotides, gene replacement therapies and gene editing represent possible future therapeutic avenues for ciliopathies, none are yet licensed (Kim and Kim, 2019). Currently, only one drug is licensed for the treatment of any ciliopathy, Tolvaptan, which has been shown to slow the decline of renal function for patients with autosomal dominant polycystic kidney disease (ADPKD) (Torres et al., 2012, 2017). Tolvaptan is a selective vasopressin V2 receptor antagonist, which ultimately decreases cAMP, reduces activation of protein kinase A and decreases the number of aquaporin channels in the collecting ducts of the kidney (Torres et al., 2012, 2017). This increases water excretion and helps to reduce cyst swelling, slowing decline in kidney function (; Wang et al., 2008; Meijer et al., 2011; Torres et al., 2012). Unfortunately, Tolvaptan is poorly tolerated due to its common side effects, including polyuria, increased thirst, pollakiuria and xerostomia (), as well as liver damage that resolves upon discontinuation of the drug treatment (Torres et al., 2012). Many other trials are ongoing, including agents to reduce obesity in Bardet-Biedl syndrome and Alström syndrome (NCT03746522) and neurotrophic (NCT00447993 and NCT0447980), anti-apoptotic drugs (Rossetti et al., 1990; Piano et al., 2013; ) and antioxidants () to treat retinal diseases. Pharmacological agents (for example, the cyclin-dependent kinase inhibitors (R)-roscovitine or the derivative (S)-CR8) that shorten cilia have been tested in animal models of ADPKD with some success (). In addition, many small molecule screens have highlighted several promising compounds and target signaling pathways for further testing (; ; Kim et al., 2018).
Understanding of cilia and ciliogenesis will be key to formulating new treatments for ciliopathies. Cilia form cells in G1 or G0 when the mother centriole docks at the apical cell membrane to form the basal body. This event prompts the local clearance of the layer of cortical actin bound to the plasma membrane (). Microtubules then nucleate at the basal body to initiate the formation of the axoneme. Ciliogenesis is therefore dependent on the cell cycle, is modified by inputs from signaling pathways, but is also heavily influenced by the actin cytoskeleton.
The actin cytoskeleton is composed of microfilaments that are formed from filamentous (F) polymers of globular G-actin subunits (Lodish et al., 2000; Figure 1, left inset). Actin filaments are organized into bundles and networks that are attached to the cell membrane by diverse cross-linking proteins. During cell migration, actin filament bundles form either radially at the leading edge or as axial stress fibers. Early studies demonstrated that loss-of-function mutations in ciliopathy genes increased stress fiber formation and impaired ciliogenesis (; Valente et al., 2010) whereas pharmacological inhibition of actin polymerization promoted ciliogenesis (; Kim et al., 2010; Sharma et al., 2011). These studies suggested that polymerization of the actin cytoskeleton, F-actin branching and the formation of stress fibers all negatively influence primary cilium formation, whereas depolymerization or depletion of actin enhances ciliogenesis (; Malicki and Johnson, 2017). Further support that perturbation of the actin cytoskeleton affects ciliogenesis came from a functional genomics screen to identify positive and negative regulators of ciliogenesis (Kim et al., 2010).
Here we review the current understanding of how the actin cytoskeleton influences ciliogenesis and cilia-dependent cellular functions, such as the maintenance of apico-basal polarity, and the mechanistic basis for these effects. We also discuss the potential for the use of this knowledge to highlight new targets for disease-modifying therapeutic approaches in treating ciliopathies. We do not discuss the roles of signaling pathways mediated by cilia that affect the actin cytoskeleton. Instead, we direct the reader to another recent review which covers this topic ().
The Actin Cytoskeleton
Actin was discovered in 1887, initially named “myosin ferment” (), it was then isolated from muscle preparations in 1942 (Straub, 1942). It was not until the 1960s that actin was detected in non-muscle cells (; Miki-Noumura and Oosawa, 1969). Actin is an abundant, intracellular cytoskeletal protein that is ubiquitous in eukaryotic cells. There are different isoforms, each encoded by one of six genes in mammals [reviewed in Perrin and Ervasti (2010)]. Actin also undergoes various post translational modifications that are important to its functions [reviewed in Varland et al. (2019)]. It can be present as a free monomer, namely globular actin (G-actin), or polymerized into linear filamentous actin (F-actin) (Straub, 1943). F-actin is a major component of the cytoskeleton, a dynamic network that supports and maintains cellular shape and polarity, whilst also enabling cells to migrate. F-actin is present in cells in part as a microfilament network, which makes up the cortical actin layer that supports the cell membrane. The spontaneous formation of actin filaments in high salt conditions hindered efforts to crystallize actin for structural analysis. High resolution crystal structures of both G-actin and F-actin were finally reported in 1990 (; ). The 43kDa G-actin molecule is folded into two similarly sized domains, separated by a cleft that harbors a binding pocket for small molecules, for example ATP in vivo or inhibitors ().
F-actin is a dynamic polymer with structural polarity due to the common orientation of its subunits. It consists of two twisted helices with an approximate diameter of 5–9 nm (). Conventional nomenclature for each filament end is derived from the appearance of microfilaments during transmission electron microscopy imaging of samples treated with myosin S1 fragments (the head and neck domains of non-muscle myosin II), subsequently fixed with tannic acid (). Images show myosin-stained actin filaments as “feather-ended arrows.” The positive (+) end is the “feathered” barbed end of the “arrow,” for which myosin molecules are the “feathers” and actin the “arrow” shaft. Conversely, the minus (−) end is named the pointed end because it is not decorated with myosin in this context (Figure 1, left inset).
The majority of studies of actin polymerization and depolymerization have been carried out in vitro rather than in vivo. In vivo dynamic actin processes are estimated to occur at least 100 times faster than in vitro (Zigmond, 1993) and are likely controlled by the cumulative effects of many different proteins, meaning that the in vivo processes are hard to study. The complexity and speed of signals and responses also show how specific and rapid the modulation of the actin cytoskeleton can be to different stimuli.
Within cells, both polymerization and depolymerization require actin binding proteins (Supplementary Table 1 and Figure 1, right inset). Actin polymerization occurs when G-actin monomers nucleate to initiate the formation of the F-actin polymer. This requires nucleating factors, such as Spire or formins, or the actin-related protein complex (ARP2/3) which can also act to create branches within filaments (; ). Many other proteins alter actin polymerization and depolymerization kinetics through a variety of other mechanisms. These include binding actin monomers and capping, crosslinking and stabilizing actin filaments (Figure 1, right inset). There are also many actin-binding proteins responsible for actin depolymerization, although this remains incompletely understood. Members of the yeast actin depolymerization factor (ADF)/cofilin family can both enhance dissociation of monomers from the (−) end () and can sever filaments to create additional (−) ends (Maciver et al., 1998).
F-actin branching is important in the formation of cellular protrusions, including cilia, lamellipodia and microvilli, and is mediated through the action of the actin-related protein complex (ARP2/3) and Wiskott-Aldrich syndrome proteins (WASp) (). ARP2/3 creates branches at 70° to the plane of the original actin filaments which help to establish a supportive meshwork for membrane protrusions (Mullins et al., 1998). Branching is an important consideration in disassembly too, since ADF/cofilin preferentially disassembles branched networks rather than either parallel or antiparallel filament bundles (). Filament severing then occurs at the boundaries between bare and cofilin-bound filament segments, so that cofilin binding density regulates overall filament length (Suarez et al., 2011).
Actin binds and can hydrolyze ATP to ADP (Pollard et al., 2000). This ability, in part, creates the polarity of the actin filaments, along with the preferential additional of monomers to the (+) end of the polymer. Although ATP hydrolysis is not itself required for polymerization (), the critical concentration of actin required for polymerization to occur is lower when ATP is bound to G-actin monomers, than when ADP is bound. ATP is hydrolyzed upon filament assembly and makes filaments stiffer (), but this process lags behind monomer additions, creating a gradient of decreasing ATP-bound actin towards the (−) end of the filament (; ). The preferential dissociation of ADP-bound actin results in a “treadmilling” effect, whereby the F-actin filaments exhibit net growth at their (+) ends and net dissociation at their (−) ends (Wegner, 1982). The effect of treadmilling is to create protrusive force in one direction which can be harnessed by motile cells through the formation of structures such as lamellipodia, which are transient actin filament-filled membrane protrusions (). Microvilli are also cellular membrane projections formed by treadmilling (Lodish et al., 2000). These dynamic equilibria within actin regulation present another opportunity for modulation by actin binding proteins. Some proteins act by sequestering ATP-bound G-actin monomers to negatively affect filament growth, for example, thymosin beta 4 (). Others enhance the nucleotide exchange properties of actin to promote growth, for example profilin ().
F-actin also forms microfilament bundles which, together with non-muscle myosin-based motor proteins and actin cross-linking proteins, form stress fibers. Stress fibers are contractile bundles of 10–30 actin filaments, crosslinked by alpha-actinin, found in non-muscle cells with important roles in adhesion, migration, morphogenesis and mechanotransduction (Tojkander et al., 2012). Within stress fibers, myosin II protein can slide along individual actin filaments but non-muscle myosin II can also form bipolar filaments whereby the myosin II heads can also attach to different actin filaments, sliding one actin filament against another to create contractile force (Vicente-Manzanares et al., 2009). Stress fibers vary greatly in their morphology and attachment to focal adhesions, and the processes of their formation and modulation are incompletely understood. Cytokinetic rings, which form during the final step of cell division are another example of a contractile, non-muscle, acto-myosin structure in animal cells (Miller, 2011).
Overall, the highly dynamic and responsive turnover of actin microfilaments enables the rapid reorganization of the actin cytoskeleton in response to extracellular and intracellular cues, particularly for processes dependent on membrane remodeling such as endocytosis and cytokinesis () and the long-range intracellular transport of vesicles (Schuh, 2011). The large number of proteins that actin is known to interact with (>150 actin binding proteins) provides extensive opportunity for localized fine-tuning of the actin cytoskeleton (Schoenenberger et al., 2011).
Actin Inhibitors and Detection Reagents
Pharmacological perturbation of actin dynamics has been used to study actin structures within cells. Chemicals that destabilize or stabilize actin filaments, or that prevent or enhance polymerization, have been used extensively. However, results need to be interpreted with caution, since these agents cause global and extreme alterations of the actin cytoskeleton rather than the small, localized changes that would be typical in vivo.
The chemicals most often used to destabilize actin experimentally are a group of fungal metabolites called cytochalasins. Cytochalasin D is most often used to perturb actin dynamics because of its favorable inhibition kinetics and better specificity in comparison to other cytochalasins (). Cytochalasin D resembles capping proteins which block the extension of actin filaments, since it binds the barbed (+) end of the filament (). Cytochalasin D also binds actin monomers and hydrolyses ATP to decrease the pool of ATP-bound actin available for polymerization (). Treatment of the ciliated hTERT RPE-1 cell-line, at low density in growth-promoting medium, with 0.5 μM cytochalasin D significantly induced ciliogenesis within 8–12 h (Kim et al., 2010; Nagai and Mizuno, 2017). Cytochalasin D treatment at 200 nM was also shown to increase cilia length after only 1 h, in parallel with actin cytoskeleton remodeling that promoted the directional trafficking of ciliary vesicles towards the ciliary base (). Additionally, the authors showed that cytochalasin D treatment resulted in inactivation of the Hippo pathway transcriptional co-activators YAP (yes-associated protein) and TAZ (transcriptional coactivator with PDZ-binding motif, also known as WWTR1) (). These act as the two primary sensors of a cell’s structure, shape and polarity (Piccolo et al., 2014) and typically promote cell proliferation when active (Pan, 2010).
Latrunculin was originally isolated from various marine sponges and is also used experimentally to depolymerize actin (Spector et al., 1983). Latrunculin A is the more potent of the two most common isoforms (A and B) (Spector et al., 1989). Latrunculin binds actin monomers to prevent them from polymerizing (; Morton et al., 2000). Treatment of hTERT RPE-1 cells with 1 μM latrunculin B significantly induced ciliogenesis within 24 h (Nagai and Mizuno, 2017). Jasplakinolide is another compound originally isolated from marine sponges that both promotes actin polymerization and stabilizes filaments (). It is cell membrane permeable, making it ideal for the treatment of live cells (Matthews et al., 1997), and treatment of hTERT RPE-1 cells with 1 μM jasplakinolide significantly induced ciliogenesis within 12 h (Nagai and Mizuno, 2017). However, jasplakinolide treatment did not increase in ciliogenesis in cells plated at higher density (Nagai and Mizuno, 2017), contradicting the predicted effect of a chemical that promotes actin polymerization and should therefore suppress ciliogenesis. However, similar to the effect of the actin destabilizer cytochalasin D (), jasplakinolide treatment also caused cell rounding, reduced cell adherence and proliferation, and inactivation of the transcriptional co-activator YAP (Nagai and Mizuno, 2017). This reiterates the point that pharmacological perturbation of the actin cytoskeleton can cause unexpected effects on ciliogenesis, likely due to the off-target effects of the inhibitor.
Phalloidin is a toxin originally obtained from the death cap mushroom (Lynen and Wieland, 1938) and is mainly used to label F-actin but it also acts to stabilize filaments (Wieland, 1977). Its effectiveness as a toxin, namely its strong specific binding to F-actin (Kd 0.27 μM), is exactly what has made it a useful research tool. As previously mentioned, electron microscopy of actin initially focused on the use of myosin to “decorate” actin filaments to reveal their polarity (). Antibodies to actin were created as early as 1979 (Lazarides and Weber, 1974). However, the strong evolutionary conservation of actin makes it a notoriously weak immunogen and so other detection methods were sought. Phalloidin binds F-actin with much greater affinity than G-actin making it ideal to visualize actin structures. However, binding also stabilizes F-actin up to seven actin subunits from the binding site (Visegrády et al., 2005), preventing depolymerization. Stable actin aggregates can form as a result of phalloidin treatment of live cells (Wehland et al., 1977), so the stain must be used at very low concentrations to prevent artifacts. It also preferentially stains the ends of actin structures and might not stain all F-actin structures in vivo (Visegrády et al., 2005). Those caveats, plus its slow dissociation rate from F-actin and the need to microinject it into live cells, mean that phalloidin is instead most often used to stain fixed preparations where it remains the gold-standard actin stain (Figures 2A–C). Despite this, use of phalloidin, either as a directly labeled stain or as an agent applied to stabilize actin filaments, allowed the first visualizations of individual actin filaments (Yanagida et al., 1984; ). Observation of individual actin filaments and their dynamics without the interference of phalloidin was only possible with the use of alternative imaging techniques such as total internal reflection fluorescence microscopy ().
FIGURE 2
Actin-green fluorescent protein (GFP) fusion proteins have been used as an alternative to phalloidin in early live-staining studies of the actin cytoskeleton. However, GFP-tagged actin monomers polymerize less efficiently than endogenous actin (Yamada et al., 2005) and have therefore been associated with altered actin structure and dynamics (Spracklen et al., 2014). Actin-binding domains fused to GFP have been used to stain live cells with more success. These have utilized actin binding domains obtained from moesin in Drosophila melanogaster (
For all of these detection moieties, the fluorescent fusion protein and even the linker sequence used can alter the subset of F-actin labeled by the marker (Lemieux et al., 2014). More recently, chemically synthesized silicon-rhodamine (SiR) based probes such as SiR-actin have been reported (Lukinavičius et al., 2014). SiR probes exist in a zwitterion state, of which the fluorescent “on” state is promoted by interaction with polar protein surfaces whereas the non-fluorescent “off” state is promoted by aggregation or binding to hydrophobic surfaces (Lukinavičius et al., 2013). These probes are cell permeable and therefore do not require transfection or over-expression, but there are practical limitations because SiR only emits fluorescence in far-red and SiR-actin is derived from jasplakinolide so is likely to perturb actin polymerization and F-actin stabilization (Melak et al., 2017). Chromobodies have also been used to visualize actin dynamics in live cells (Rocchetti et al., 2014) and even whole organisms (Panza et al., 2015). Chromobodies are nanobodies, the antigen binding domain of single heavy-chain antibodies found in Camelidae (
Cilia and the Actin Cytoskeleton
The close associations between cilia and the actin cytoskeleton are clear from the outset of ciliogenesis, with the requirement of the actin cytoskeleton for centrosome/basal body migration and the anchoring of the cilia to the actin cytoskeleton by focal adhesion complexes (
F-actin has also been detected as a pool at the base of the cilium within the ciliary pocket (Molla-Herman et al., 2010). The ciliary pocket consists of a membrane invagination that is maintained by stable and dynamic actin filaments, in which the more dynamic actin is found at the distal end of the ciliary pocket in order to facilitate directional ciliary vesicle trafficking of ciliary cargo (Molla-Herman et al., 2010). This distal region undergoes clathrin-mediated endocytosis in response to phosphorylated dynein light chain Tctex-type 1 (DYNLT1) translocating to the transition zone, prior to S phase entry (Li et al., 2011; Saito et al., 2017). Phosphorylated DYNLT1 stimulates F-actin polymerization in the ciliary pocket by binding to actin and recruiting other regulators of actin polymerization (Saito et al., 2017), which is proposed to be one of the earliest steps in ciliary disassembly (Li et al., 2011).
Actin and Regulation of Ciliogenesis Initiation and Cilia Length
Due to the high volume of traffic into and out of the cilium during normal cell homeostasis, ciliary maintenance and stability is essential for its function. The constant renewal of ciliary membrane proteins and transduction of signal requires functional IFT and delivery of cargo from the cytoplasm to the cilium. Currently, the mechanism for the delivery of ciliary membrane proteins is not fully understood. It is thought that ciliary cargo is arranged into ciliary-specific vesicles at the trans Golgi network. These marked vesicles are thought to be trafficked along the actin cytoskeleton (Kim et al., 2010,
The timing of actin dynamics and the exact role in ciliogenesis still requires further research, as it is poorly understood. Currently these dynamics are only modeled with global actin changes, which do not reflect the likely local and nuanced changes during normal ciliogenesis. In general, actin depolymerization, through either siRNA knock-down of actin regulators or pharmacological inhibition of actin polymerization with cytochalasin D, promotes ciliogenesis in all cell culture conditions (confluency and presence/absence of serum). Early studies have shown that pharmacological inhibition of actin polymerization promoted ciliogenesis and, furthermore, actin remodeling can transcriptionally control key negative regulators of ciliary disassembly Aurora A and Plk1 (
A large “druggable library” siRNA screen, that was published in 2010, sought to identify modulators of ciliogenesis and cilia length (Kim et al., 2010). The two main regulators that were further investigated were gelsolin (GSN), a positive regulator, and actin-related protein 3 (ACTR3), a negative regulator. Both are involved in the regulation of actin filament stabilization: GSN severs actin filaments and ACTR3 inhibits branching. Knock-downs of these genes, in parallel with cytochalasin D treatment suggested an important role of branched F-actin in modulating ciliogenesis, with dynamic or destabilized actin promoting ciliogenesis and increased cilia length. Cytochalasin D has also independently been shown to rescue ciliogenesis following siRNA knock-down of the important ciliary genes CEP290, NPHP5, and IFT88 (
A subsequent study identified LIMK2 and TESK1, two separate actin regulators exerting effects on cilia incidence (
To gain further mechanistic insight, further studies have assessed the possible role of non-muscle myosins in the remodeling of actin during ciliogenesis (
Actin at the Ciliary Tip
In comparison to proximal regions of the cilium, the ciliary tip has a different composition of proteins, including clathrins and actin, probably because it is a source of extracellular vesicles (ECV). The best investigated ECVs are from the retina outer segment, which allow recycling of opsins through endocytosis of ECVs by the retinal pigment epithelial cells (Young and Bok, 1969). In other cell types, ECVs are poorly characterized, but purified ECVs have been shown to contain ciliary proteins and transmembrane signaling molecules (
Actin and Ciliary Stability
In addition to negative modulation of ciliogenesis and cilia length, actin has also been implicated in maintaining ciliary stability. Human and mouse mutant models of KDM3A, a multifunctional protein shown to have roles as a transcription factor for free actin, have reduced cellular actin levels and an associated increase in cilia (Yeyati et al., 2017). As there are decreased levels of actin around the base of the cilium in Kdm3a mutants, it was proposed that the loss of this physical gate would allow for an increase in IFT at the cilium, disrupting the balance of transport proteins (Yeyati et al., 2017). This dysregulation is further compounded by actin instability causing an increase in cilia length, further disrupting the balance and regulation of IFT (Yeyati et al., 2017).
Role of Actin in Motile Cilia and Multiciliated Cells
Although there is compelling evidence for a functional role for actin destabilization in promoting ciliogenesis of primary cilia, in multiciliated cells there is support for the opposite effect (Pan et al., 2007). Multiciliated cells require basal bodies to both dock with the cell membrane and to establish polarity so that the cilia formed may beat in synchrony to establish fluid flow (
Actin Binding Proteins, Ciliogenesis and Cilia Maintenance
Following on from the seminal large “druggable library” siRNA screen by Kim et al., which identified a number of actin binding proteins as modulators of ciliogenesis and cilia length (Kim et al., 2010), more recent studies have identified additional actin binding proteins that have novel and unexpected roles in ciliogenesis and ciliary maintenance. Here we discuss several actin binding proteins that have been studied in the most detail.
Filamin A
Filamin A (FLNA, previously named FLN1 and ABP-280) is one of three proteins in the filamin family (Figure 2C). Filamins anchor the actin cytoskeleton to the cell membrane by crosslinking actin into networks in the cortical cytoplasm (Nakamura et al., 2011). They can also bundle actin into stress fibers (
FLNA was first linked to centrosomal trafficking and initiation of ciliogenesis through the identification of a patient with both MKS and PH (
More recently, it has been suggested that transforming acidic coiled-coil protein 3 (TACC3) may compete with TMEM67 (meckelin) for FLNA binding (Qie et al., 2020). TACC3 is up-regulated in prostate cancer (Qie et al., 2020) and it promotes cell growth and differentiation in a number of other cancers (Lauffart et al., 2005;
RhoA
RhoA is the activator of ROCK, a key actin remodeling regulator that is responsible for the formation of stress fibers (Ridley and Hall, 1992). RhoA has been shown to contribute to the molecular pathology of ciliopathies: increased RhoA levels were observed in dermal fibroblasts from ciliopathy patients with TMEM216 mutations (Valente et al., 2010). Independently, RhoA has also been shown to mislocalize in patients with JBTS syndrome (specifically caused by TMEM237 mutations), and patient fibroblasts had increased actin stress fibers (
The cellular phenotypes observed in many ciliopathies are suggested to be due to defects of the actin cytoskeleton (Valente et al., 2010;
Synaptic Nuclear Envelope Protein 2
Synaptic nuclear envelope protein 2 (SYNE2) is a member of the nuclear envelope spectrin repeat (nesprin) family of proteins that comprises four members (Rajgor and Shanahan, 2013). Previously named nesprin-2, SYNE2 is a modular protein with N-terminal paired calponin homology (CH) domains, a C-terminal Klarsicht/ANC-1/Syne homology (KASH) transmembrane domain that acts as a nuclear envelope targeting motif (Zhen et al., 2002), and a central extended spectrin repeat rod domain thereby tethering the nucleus to the cytoskeleton. SYNE2 binds to cytoplasmic F-actin directly through its actin-binding CH domains, but also itself binds FH1/FH2 domain-containing protein 1 (FHOD1) and fascins (FSCN1, FSCN2, FSCN3) which also bind actin (
SYNE2 was first linked to centrosome trafficking and early ciliogenesis, when it was shown that a splice variant lacking the KASH domain interacts with two MKS proteins (MKS1 and TMEM67) that are required for centrosome migration and ciliogenesis (
SYNE2 has also been shown to interact with pericentrin (PCNT) (
PCARE and Retinal Outer Segments
An example of the importance of the actin cytoskeleton in the role of cilia within specialized cell types has been highlighted in a recent paper on photoreceptors (
Photoreceptor cilium actin regulator (PCARE, previously named C2orf71; Figure 3) was first identified when it was shown to be mutated in a subset of retinitis pigmentosa patients (RP54) (
FIGURE 3

Ciliary membrane remodeling of the actin-binding protein PCARE in the primary cilium and photoreceptor connecting cilium. The proposed role of PCARE in the cilium (left panel) and in the specialized cilium of the photoreceptor outer segment and connecting cilium (right panel) are indicated. PCARE (red) has been shown to interact with actin-binding proteins (dark red symbols) associated with de novo F-actin network assembly including the ARP2/3 complex, gelsolin, profilin and WASF3 (orange). PCARE in mice localizes to the basal body, the microtubules of the connecting cilium and extends into the newer outer segment discs (
Leucine Zipper Protein 1
Another important actin binding protein implicated in ciliogenesis is leucine zipper protein 1 (LUZP1) (Wang and Nakamura, 2019). In cycling cells, LUZP1 localizes to the pericentriolar matrix at the proximal end of each centriole, the actin cytoskeleton and the midbody (
Proximity Labeling Studies
Studies utilizing proximity labeling to identify ciliary proteins have reported varied results for detection of actin binding proteins (Mick et al., 2015; Kohli et al., 2017). One study revealed a surprising number of actin binding proteins within cilia (Kohli et al., 2017). Kohli et al. used enzyme-catalyzed proximity labeling with an engineered ascorbate peroxidase (APEX2) that was specifically targeted to the ciliary membrane (Kohli et al., 2017). Actin-binding proteins that were identified in close proximity to the ciliary membrane included activins, tropomyosins, coronin, ezrin, gelsolin, cortactin, utrophin, drebrin-like protein, and, most abundantly, alpha-activin and filamin A (Kohli et al., 2017). However, it was unclear if proximity labeling was also tagging actin-binding proteins during trafficking of the construct at the ciliary pocket which would argue against a specific role for these proteins within cilia. Paradoxically, levels of these actin binding proteins increased in the ciliary compartment after cells were treated with the actin-depolymerizing agent cytochalasin D (see above). An earlier study, utilizing APEX that was specifically targeted to the ciliary lumen using nephrocystin 3, failed to detect actin binding proteins within the cilium (Mick et al., 2015).
Actin depolymerization may therefore trigger the recruitment of actin-binding proteins to the cilium (Kohli et al., 2017), but it remains unclear how this leads to axonemal extension and cilium elongation, and whether actin-binding proteins have a direct role in this process. It is possible that actin de-polymerization causes the non-specific release of the pool of proteins normally bound to F-actin at the ciliary pocket and subsequent ectopic release into the ciliary compartment.
Pharmacological Inhibition of Actin Remodeling
Interest in modification of the actin cytoskeleton as a possible treatment for ciliopathies grew from the finding that positive regulators of actin polymerization exerted negative effects on ciliogenesis and vice versa (Kim et al., 2010). Kim et al. (2010) also found that cytochalasin D treatment, which prevents actin polymerization, significantly rescued the ciliogenesis defect in hypomorphic IFT88 mutant cells (Ift88orpk/orpk). Cytochalasin D is unsuitable for treatment of ciliopathies in whole organisms because of the effects of global inhibition of actin polymerization, that include failure of cytokinesis, aneuploidy, cell cycle arrest and apoptosis, as well as off-target effects of the inhibitor. However, other inhibitors that target actin modulators implicated in ciliogenesis have been suggested to be more suitable for pharmacological intervention and treatment (Kim et al., 2010).
Drugs that act on actin binding proteins and increase cilia incidence could also be valuable for diseases of spontaneous epithelial-mesenchymal transition and uncontrolled cell division such as cancer (
Identification of Therapeutics for Cystic Kidney Disease
Several drugs screens have been completed to identify compounds that could be used to modulate the actin cytoskeleton and increase ciliogenesis (Table 1). These screens have focused on the kidney since polycystic kidney disease is relatively common [4 in 10,000 in Europe (Willey et al., 2017)] and cystic kidney disease is a common feature of many ciliopathies (
TABLE 1
| Cell line/origin | Mutational model | Cell culture | Stimulation | Drug library | Methodology | Output (assay markers) | Validation | Hit categories | Specific Hits | References |
| CFPAC-1 | wild-type | 2D | none | Pharmakon 1600 | 10 μM with 2 × 4 day exposure | % ciliated cells (acetylated alpha-tubulin) | assays of hit compounds in four other cancer cell-lines | 118 hits: 49 glucocorticoids, fibrates or other nuclear receptor modulator; 14 neurotransmitter modulators; other include ion channel modulators, tyrosine kinase inhibitors | cilia incidence: clofibrate, gefitinib, sirolimus; cilia length: imexon, clofibrate, xylazine | PMID:26862738 |
| mIMCD3 | Pkd1–/–a | 3D | forskolin treatment | L1200 SelleckChem (273 kinase inhibitors) | 0.1 and 1 μM forskolin for 72 h | cyst size (F-actin and nuclei) | dose response assays of hit compounds | inhibitors targeting mTOR, Aurora A kinase, CDK, IGF-1R, and dual mTOR/PI3K inhibitors | torin 1 and torin 2 | PMID:28644734 |
| MEK | Pkd1–/–, Pkd1+/– and wild-type | 2D screen, 3D validation | none | NIH Pharmaceutical Collection (NPC) and other collections (8814 compounds) | various concentrations over 48 h, followed by comparison between different genotypes | cell proliferation (fluorescence assay), ATP levels (luminescence assay) | re-testing fresh hit compounds, dose response and 3D cyst assays in murine cell; assays in human ADPKD cells and normal kidney cells | 155 hits from 2D screen: HMG-CoA reductase, HSP90, tubulin depolymerization and other inhibitors; 109 hits validated in 3D models; 21 hits validated in human ADPKD cells | 3D models: epothilone A, GSK-269962A, 5-azacytidine, tosedostat; human ADPKD cells: gemcitabine, niclosamide, cerivastatin | PMID:32144367 |
| mIMCD3 | Pkd1–/–b | 3D | none | Cayman Chemicals #10505 (155 kinase inhibitors) | 6 day treatment, various concentrations 1-33 μM | % cord/tubule vs. cysts (F-actin) | treatment of conditional AhCre; Pkd1flox/flox mouse model with Y-27632c | 5 hits: ROCK inhibitors | Y-27632, HA-1077, H-89, (S)-H-1152, (S)-Glycyl-H-1152 | PMID:29891559 |
Drug screens to identify compounds that modulate the actin cytoskeleton and increase ciliogenesis.
CFPAC-1, ductal pancreatic adenocarcinoma cell-line; mIMCD3, murine inner medullary collecting duct kidney epithelial cell-line; MEK, murine embryonic kidney cells derived from collecting duct and post-natal proximal tubule cells. aEngineered using lentiviral transfection. bEngineered using CRISPR-Cas9 gene editing. cNo other specific validation of hit compounds; further experiments focused on the RhoA-YAP-cMyc signaling pathway.
Of the tens of drugs screens carried out, one screen of 1600 compounds identified 118 hits that restored cilia expression in the CFPAC-1 pancreatic cancer cell line (
Several other small molecule screens have highlighted inhibition of ROCK, amongst many other pathways, as a potential therapeutic for cystic kidney disease. One study screened 273 kinase inhibitors in a forskolin-stimulated 3D cyst assay using an IMCD3 cell line expressing a short hairpin RNA targeting polycystin 1 transcripts and identified thiazovivin (a non-selective ROCK inhibitor) as a significant hit (
One recent screen assessed the effects of 8,814 compounds, mostly with proven anti-neoplastic effects, on autosomal dominant polycystic kidney disease type 1 (ADPKD1) adult and fetal cell models (
In support of the potential repurposing of known ROCK inhibitors, one study demonstrated rescue of cord and tubule formation whilst reducing cyst formation in the cystogenic Pkd1 knock-out 3D kidney cell-line model (
Aside from screens, ROCK inhibitors have also been shown to restore cilia in a Rho GTPase activating protein (GAP) mutant mouse model (Arhgap35D34/D34) that had reduced cilia incidence and length (Stewart et al., 2016). This Rho-GAP mutant had increased RhoA activation as a result of reduced intrinsic hydrolytic activity due to inactivation of ARHGAP35. The mutant mouse model also displayed a glomerulocystic kidney phenotype, thus linking RhoA hyperactivity and failures in ciliogenesis to cystogenesis (Stewart et al., 2016). Further investigation identified a reduction in cilia within the proximal tubule during development, resulting from a failure in axoneme elongation rather than basal body migration or docking (Stewart et al., 2016). The authors concluded that local negative regulation of Rho-GAPs is required at the ciliary base to enable axoneme extension (Stewart et al., 2016). A more recent study reported that dysregulation of RhoA signaling at the centrosome, mediated by ARHGAP35, led to increased activation of ROCKs in mutant or null PKD1 cells (Streets et al., 2020). The authors found that treatment of PKD1 patient cells and an inducible, kidney specific Pkd–/– mouse model with the ROCK inhibitor hydroxyfasudil reduced cyst size over 7 days of treatment (Streets et al., 2020). Collectively, these findings call for the assessment of the effects of different ROCK inhibitors on cyst growth and development in human cell and animal models. Assessment of the relative contributions of F-actin stabilization and acto-myosin contraction to ciliogenesis and cilia maintenance over different time periods will be key to understanding how ROCK inhibitors modulate cilia. Parallel investigations should also assess the effect on ROCK inhibition on ciliary-mediated signaling functions.
Conclusion and Future Directions
It is now recognized that the centrosome acts as both a microtubule and actin organizing center, and therefore that the actin cytoskeleton and ciliogenesis are intrinsically linked. It is also clear that the actin cytoskeleton exerts multiple effects on ciliogenesis, cilia maintenance, signaling and function, making it an important potential drug target. The large number of actin-binding proteins that are involved in actin dynamics, often in cell-specific processes, means that targeting can be potentially fine-tuned depending upon the cell type. Greater understanding of actin remodeling will come from improved actin detection and visualization of highly dynamic remodeling events, including the use of super-resolution microscopy and the use of proximity labeling studies to identify novel actin binding proteins.
In the next stages of this research, additional screens of candidate drugs or small molecules should be completed, using a number of different models of cystic kidney disease, with different genetic aberrations and backgrounds and with treatment at different disease stages. These studies will be required to discern whether inhibitors of ROCK or other targets that modulate the actin cytoskeleton may have potential clinical efficacy in the treatment of cystic kidney diseases. These screens will also help to determine the points at which disease can be ameliorated and which disease stage would be most amenable to the effects of each drug. RNA expression profiling of ADPKD and Pkd1–/– kidney cysts compared with healthy kidney tissue supports the targeting of the RhoA-YAP-cMyc axis (
Statements
Author contributions
CS, AL, and CJ drafted the manuscript and figures. All authors gave final approval and agreed to be accountable for all aspects of the work.
Funding
CS and CJ were funded by Action Medical Research (Project Grant No. GN2628). AL and CJ were funded by UKRI (BBSRC-SFI Joint Project Grant No. BB/P007791/1). CJ would also like to acknowledge funding from Newlife the Charity for Disabled Children (Project Grant No. 12-13/11).
Acknowledgments
We are grateful to Michelle Peckham, University of Leeds, for microscopy images. We would like to thank members of the Johnson group for critical reading of draft versions of the manuscript.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Supplementary material
The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fcell.2020.622822/full#supplementary-material
References
1
AdamsM.SimmsR. J.AbdelhamedZ.DaweH. R.SzymanskaK.LoganC. V.et al (2012). A meckelin-filamin A interaction mediates ciliogenesis.Hum. Mol. Genet.211272–1286. 10.1093/hmg/ddr557
2
AjzebergH.SlaatsG.StokmanM.LogisterI.KnoersN.GilesR. (2015). Urine-derived Renal Epithelial Cells (URECs) as a source of biomaterial from ciliopathy patients for functional studies and diagnostics.Cilia451–51. 10.1186/2046-2530-4-S1-P51
3
AntoniadesI.StylianouP.SkouridesP. A. (2014). Making the connection: ciliary adhesion complexes anchor basal bodies to the actin cytoskeleton.Dev. Cell2870–80. 10.1016/j.devcel.2013.12.003
4
AsawaR. R.DanchikC.ZahkarovA.ChenY.VossT.JadhavA.et al (2020). A high-throughput screening platform for Polycystic Kidney Disease (PKD) drug repurposing utilizing murine and human ADPKD cells.Sci. Rep.10:4203. 10.1038/s41598-020-61082-3
5
AtilganE.WirtzD.SunS. X. (2006). Mechanics and dynamics of actin-driven thin membrane protrusions.Biophys. J.9065–76. 10.1529/biophysj.105.071480
6
AtkinsonK. F.KathemS. H.JinX.MunteanB. S.Abou-AlaiwiW. A.NauliA. M.et al (2015). Dopaminergic signaling within the primary cilia in the renovascular system.Front. Physiol.6:103. 10.3389/fphys.2015.00103
7
AvasthiP.MarshallW. F. (2012). Stages of ciliogenesis and regulation of ciliary length.Differentiation83S30–S42. 10.1016/j.diff.2011.11.015
8
BarbelanneM.SongJ.AhmadzaiM.TsangW. Y. (2013). Pathogenic NPHP5 mutations impair protein interaction with Cep290, a prerequisite for ciliogenesis.Hum. Mol. Genet.222482–2494. 10.1093/hmg/ddt100
9
BeggD. A.RodewaldR.RebhunL. I. (1978). The visualization of actin filament polarity in thin sections. Evidence for the uniform polarity of membrane-associated filaments.J. Cell Biol.79846–852. 10.1083/jcb.79.3.846
10
BelinB. J.GoinsL. M.MullinsR. D. (2014). Comparative analysis of tools for live cell imaging of actin network architecture.Bioarchitecture4189–202. 10.1080/19490992.2014.1047714
11
BershteynM.AtwoodS. X.WooW. M.LiM.OroA. E. (2010). MIM and cortactin antagonism regulates ciliogenesis and hedgehog signaling.Dev. Cell19270–283. 10.1016/j.devcel.2010.07.009
12
Boisvieux-UlrichE.LaineM. C.SandozD. (1985). The orientation of ciliary basal bodies in quail oviduct is related to the ciliary beating cycle commencement.Biol. Cell55147–150. 10.1111/j.1768-322x.1985.tb00417.x
13
Boisvieux-UlrichE.LainéM. C.SandozD. (1990). Cytochalasin D inhibits basal body migration and ciliary elongation in quail oviduct epithelium.Cell Tissue Res.259443–454. 10.1007/bf01740770
14
BooijT. H.BangeH.LeonhardW. N.YanK.FokkelmanM.KunnenS. J.et al (2017). High-throughput phenotypic screening of kinase inhibitors to identify drug targets for polycystic kidney disease.SLAS Discov.22974–984. 10.1177/2472555217716056
15
Bozal-BasterraL.Gonzalez-SantamartaM.MuratoreV.Bermejo-ArteagabeitiaA.Da FonsecaC.Barroso-GomilaO.et al (2020). LUZP1, a novel regulator of primary cilia and the actin cytoskeleton, is a contributing factor in Townes-Brocks Syndrome.eLife9:e55957. 10.7554/eLife.55957
16
Bozal-BasterraL.Martín-RuízI.PironeL.LiangY.SigurðssonJ. O.Gonzalez-SantamartaM.et al (2018). Truncated SALL1 impedes primary cilia function in townes-brocks syndrome.Am. J. Hum. Genet.102249–265. 10.1016/j.ajhg.2017.12.017
17
BretschneiderT.DiezS.AndersonK.HeuserJ.ClarkeM.Müller-TaubenbergerA.et al (2004). Dynamic actin patterns and Arp2/3 assembly at the substrate-attached surface of motile cells.Curr. Biol.141–10. 10.1016/j.cub.2003.12.005
18
BrückerL.KretschmerV.May-SimeraH. L. (2020). The entangled relationship between cilia and actin.Int. J. Biochem. Cell Biol.129:105877. 10.1016/j.biocel.2020.105877
19
BurkelB. M.von DassowG.BementW. M. (2007). Versatile fluorescent probes for actin filaments based on the actin-binding domain of utrophin.Cell Motil. Cytoskeleton64822–832. 10.1002/cm.20226
20
ByrneA. M.RocheS. L.Ruiz-LopezA. M.JacksonA. C.CotterT. G. (2016). The synthetic progestin norgestrel acts to increase LIF levels in the rd10 mouse model of retinitis pigmentosa.Mol. Vis.22264–274.
21
CaiJ.SongX.WangW.WatnickT.PeiY.QianF.et al (2018). A RhoA-YAP-c-Myc signaling axis promotes the development of polycystic kidney disease.Genes Dev.32781–793. 10.1101/gad.315127.118
22
CaoJ.ShenY.ZhuL.XuY.ZhouY.WuZ.et al (2012). miR-129-3p controls cilia assembly by regulating CP110 and actin dynamics.Nat. Cell Biol.14697–706. 10.1038/ncb2512
23
CarlierM. F. (1990). Actin polymerization and ATP hydrolysis.Adv. Biophys.2651–73. 10.1016/0065-227x(90)90007-g
24
CarlierM. F.JeanC.RiegerK. J.LenfantM.PantaloniD. (1993). Modulation of the interaction between G-actin and thymosin beta 4 by the ATP/ADP ratio: possible implication in the regulation of actin dynamics.Proc. Natl. Acad. Sci. U.S.A.905034–5038. 10.1073/pnas.90.11.5034
25
CarlierM. F.LaurentV.SantoliniJ.MelkiR.DidryD.XiaG. X.et al (1997). Actin depolymerizing factor (ADF/cofilin) enhances the rate of filament turnover: implication in actin-based motility.J. Cell Biol.1361307–1322. 10.1083/jcb.136.6.1307
26
CarlierM. F.PantaloniD.KornE. D. (1984). Steady state length distribution of F-actin under controlled fragmentation and mechanism of length redistribution following fragmentation.J. Biol. Chem.2599987–9991.
27
ChaitinM. H.BurnsideB. (1989). Actin filament polarity at the site of rod outer segment disk morphogenesis.Invest. Ophthalmol. Vis. Sci.302461–2469.
28
Chánez-ParedesS.Montoya-GarcíaA.SchnoorM. (2019). Cellular and pathophysiological consequences of Arp2/3 complex inhibition: role of inhibitory proteins and pharmacological compounds.Cell Mol. Life Sci.763349–3361. 10.1007/s00018-019-03128-y
29
ChangW.WormanH. J.GundersenG. G. (2015). Accessorizing and anchoring the LINC complex for multifunctionality.J. Cell Biol.20811–22. 10.1083/jcb.201409047
30
CollinR. W.SafiehC.LittinkK. W.ShalevS. A.GarzoziH. J.RizelL.et al (2010). Mutations in C2ORF71 cause autosomal-recessive retinitis pigmentosa.Am. J. Hum. Genet.86783–788. 10.1016/j.ajhg.2010.03.016
31
CookeR. (1975). The role of the bound nucleotide in the polymerization of actin.Biochemistry143250–3256. 10.1021/bi00685a035
32
CooperJ. A. (1987). Effects of cytochalasin and phalloidin on actin.J. Cell Biol.1051473–1478. 10.1083/jcb.105.4.1473
33
Corral-SerranoJ. C.LamersI. J. C.van ReeuwijkJ.DuijkersL.HoogendoornA. D. M.YildirimA.et al (2020). PCARE and WASF3 regulate ciliary F-actin assembly that is required for the initiation of photoreceptor outer segment disk formation.Proc. Natl. Acad. Sci. U.S.A.1179922–9931. 10.1073/pnas.1903125117
34
CouéM.BrennerS. L.SpectorI.KornE. D. (1987). Inhibition of actin polymerization by latrunculin A.FEBS Lett.213316–318. 10.1016/0014-5793(87)81513-2
35
CourtemancheN.PollardT. D.ChenQ. (2016). Avoiding artefacts when counting polymerized actin in live cells with LifeAct fused to fluorescent proteins.Nat. Cell Biol.18676–683. 10.1038/ncb3351
36
DaweH. R.AdamsM.WhewayG.SzymanskaK.LoganC. V.NoegelA. A.et al (2009). Nesprin-2 interacts with meckelin and mediates ciliogenesis via remodelling of the actin cytoskeleton.J. Cell Sci.1222716–2726. 10.1242/jcs.043794
37
DaweH. R.SmithU. M.CullinaneA. R.GerrelliD.CoxP.BadanoJ. L.et al (2007). The Meckel-Gruber Syndrome proteins MKS1 and meckelin interact and are required for primary cilium formation.Hum. Mol. Genet.16173–186. 10.1093/hmg/ddl459
38
DePinaA. S.LangfordG. M. (1999). Vesicle transport: the role of actin filaments and myosin motors.Microsc. Res. Tech.4793–106. 10.1002/(sici)1097-0029(19991015)47:2<93::aid-jemt2>3.0.co;2-p
39
DiasM. F.JooK.KempJ. A.FialhoS. L.da Silva CunhaA.Jr.et al (2018). Molecular genetics and emerging therapies for retinitis pigmentosa: Basic research and clinical perspectives.Prog. Retin. Eye Res.63107–131. 10.1016/j.preteyeres.2017.10.004
40
DominguezR. (2009). Actin filament nucleation and elongation factors – structure-function relationships.Crit. Rev. Biochem. Mol. Biol.44351–366. 10.3109/10409230903277340
41
EdwardsK. A.DemskyM.MontagueR. A.WeymouthN.KiehartD. P. (1997). GFP-moesin illuminates actin cytoskeleton dynamics in living tissue and demonstrates cell shape changes during morphogenesis in Drosophila.Dev. Biol.191103–117. 10.1006/dbio.1997.8707
42
FalkN.KesslerK.SchrammS. F.BoldtK.BecirovicE.MichalakisS.et al (2018). Functional analyses of Pericentrin and Syne-2 interaction in ciliogenesis.J. Cell Sci.131:jcs218487. 10.1242/jcs.218487
43
FloresL. R.KeelingM. C.ZhangX.SliogeryteK.GavaraN. (2019). Lifeact-GFP alters F-actin organization, cellular morphology and biophysical behaviour.Sci. Rep.9:3241. 10.1038/s41598-019-40092-w
44
FoxJ. W.LampertiE. D.EkşioğluY. Z.HongS. E.FengY.GrahamD. A.et al (1998). Mutations in filamin 1 prevent migration of cerebral cortical neurons in human periventricular heterotopia.Neuron211315–1325. 10.1016/s0896-6273(00)80651-0
45
FrancisS. S.SfakianosJ.LoB.MellmanI. (2011). A hierarchy of signals regulates entry of membrane proteins into the ciliary membrane domain in epithelial cells.J. Cell Biol.193219–233. 10.1083/jcb.201009001
46
FujiwaraI.TakahashiS.TadakumaH.FunatsuT.IshiwataS. (2002). Microscopic analysis of polymerization dynamics with individual actin filaments.Nat. Cell Biol.4666–673. 10.1038/ncb841
47
FürthauerM.González-GaitánM. (2009). Endocytosis and mitosis: a two-way relationship.Cell Cycle83311–3318. 10.4161/cc.8.20.9700
48
GansevoortR. T.AriciM.BenzingT.BirnH.CapassoG.CovicA.et al (2016). Recommendations for the use of tolvaptan in autosomal dominant polycystic kidney disease: a position statement on behalf of the ERA-EDTA working groups on inherited kidney disorders and european renal best practice.Nephrol. Dial. Transplant.31337–348. 10.1093/ndt/gfv456
49
GarciaG.IIIRaleighD. R.ReiterJ. F. (2018). How the ciliary membrane is organized inside-out to communicate outside-in.Curr. Biol.28R421–R434. 10.1016/j.cub.2018.03.010
50
GascueC.KatsanisN.BadanoJ. L. (2011). Cystic diseases of the kidney: ciliary dysfunction and cystogenic mechanisms.Pediatr. Nephrol.261181–1195. 10.1007/s00467-010-1697-5
51
GattoneV. H.IIWangX.HarrisP. C.TorresV. E. (2003). Inhibition of renal cystic disease development and progression by a vasopressin V2 receptor antagonist.Nat. Med.91323–1326. 10.1038/nm935
52
GoddetteD. W.FriedenC. (1986). Actin polymerization. The mechanism of action of cytochalasin D.J. Biol. Chem.26115974–15980.
53
Goldschmidt-ClermontP. J.MacheskyL. M.DobersteinS. K.PollardT. D. (1991). Mechanism of the interaction of human platelet profilin with actin.J. Cell Biol.1131081–1089. 10.1083/jcb.113.5.1081
54
GoleyE. D.WelchM. D. (2006). The ARP2/3 complex: an actin nucleator comes of age.Nat. Rev. Mol. Cell Biol.7713–726. 10.1038/nrm2026
55
GonçalvesJ.SharmaA.CoyaudÉLaurentE. M. N.RaughtB.PelletierL. (2020). LUZP1 and the tumor suppressor EPLIN modulate actin stability to restrict primary cilia formation.J. Cell Biol.219:e201908132. 10.1083/jcb.201908132
56
GradiloneS. A.RadtkeB. N.BogertP. S.HuangB. Q.GajdosG. B.LaRussoN. F. (2013). HDAC6 inhibition restores ciliary expression and decreases tumor growth.Cancer Res.732259–2270. 10.1158/0008-5472.Can-12-2938
57
GressinL.GuillotinA.GuérinC.BlanchoinL.MichelotA. (2015). Architecture dependence of actin filament network disassembly.Curr. Biol.251437–1447. 10.1016/j.cub.2015.04.011
58
HabbigS.LiebauM. C. (2015). Ciliopathies – from rare inherited cystic kidney diseases to basic cellular function.Mol. Cell Pediatr.2:8. 10.1186/s40348-015-0019-1
59
HalliburtonW. D. (1887). On muscle-plasma.J. Physiol.8133–202. 10.1113/jphysiol.1887.sp000252
60
Hamers-CastermanC.AtarhouchT.MuyldermansS.RobinsonG.HamersC.SongaE. B.et al (1993). Naturally occurring antibodies devoid of light chains.Nature363446–448. 10.1038/363446a0
61
HatanoS.OosawaF. (1966). Isolation and characterization of plasmodium actin.Biochim. Biophys. Acta.127488–498. 10.1016/0304-4165(66)90402-8
62
HeJ. C.YaoW.WangJ. M.SchemmerP.YangY.LiuY.et al (2016). TACC3 overexpression in cholangiocarcinoma correlates with poor prognosis and is a potential anti-cancer molecular drug target for HDAC inhibitors.Oncotarget775441–75456. 10.18632/oncotarget.12254
63
HeinM. Y.HubnerN. C.PoserI.CoxJ.NagarajN.ToyodaY.et al (2015). A human interactome in three quantitative dimensions organized by stoichiometries and abundances.Cell163712–723. 10.1016/j.cell.2015.09.053
64
Hernandez-HernandezV.PravincumarP.Diaz-FontA.May-SimeraH.JenkinsD.KnightM.et al (2013). Bardet-Biedl syndrome proteins control the cilia length through regulation of actin polymerization.Hum. Mol. Genet.223858–3868. 10.1093/hmg/ddt241
65
HirataH.TatsumiH.SokabeM. (2007). Dynamics of actin filaments during tension-dependent formation of actin bundles.Biochim. Biophys. Acta.17701115–1127. 10.1016/j.bbagen.2007.03.010
66
HoganM. C.ManganelliL.WoollardJ. R.MasyukA. I.MasyukT. V.TammachoteR.et al (2009). Characterization of PKD protein-positive exosome-like vesicles.J. Am. Soc. Nephrol.20278–288. 10.1681/ASN.2008060564
67
HolmesK. C.PoppD.GebhardW.KabschW. (1990). Atomic model of the actin filament.Nature34744–49. 10.1038/347044a0
68
HolzingerA. (2010). “Jasplakinolide: an actin-specific reagent that promotes actin polymerization,” in Cytoskeleton Methods and Protocols, 2 Edn, ed.GavinR. H. (Totowa, NJ: Humana Press), 71–87. 10.1007/978-1-60761-376-3_4
69
HondaH.NagashimaH.AsakuraS. (1986). Directional movement of F-actin in vitro.J. Mol. Biol.191131–133. 10.1016/0022-2836(86)90428-6
70
HongH.KimJ.KimJ. (2015). Myosin heavy chain 10 (MYH10) is required for centriole migration during the biogenesis of primary cilia.Biochem. Biophys. Res. Commun.461180–185. 10.1016/j.bbrc.2015.04.028
71
HuangL.SzymanskaK.JensenV. L.JaneckeA. R.InnesA. M.DavisE. E.et al (2011). TMEM237 is mutated in individuals with a Joubert syndrome related disorder and expands the role of the TMEM family at the ciliary transition zone.Am. J. Hum. Genet.89713–730. 10.1016/j.ajhg.2011.11.005
72
HuangT.YouY.SpoorM. S.RicherE. J.KudvaV. V.PaigeR. C.et al (2003). Foxj1 is required for apical localization of ezrin in airway epithelial cells.J. Cell Sci.1164935–4945. 10.1242/jcs.00830
73
HuangfuD.LiuA.RakemanA. S.MurciaN. S.NiswanderL.AndersonK. V. (2003). Hedgehog signalling in the mouse requires intraflagellar transport proteins.Nature42683–87. 10.1038/nature02061
74
HussonH.MorenoS.SmithL. A.SmithM. M.RussoR. J.PitstickR.et al (2016). Reduction of ciliary length through pharmacologic or genetic inhibition of CDK5 attenuates polycystic kidney disease in a model of nephronophthisis.Hum. Mol. Genet.252245–2255. 10.1093/hmg/ddw093
75
IoannouA.SantamaN.SkouridesP. A. (2013). Xenopus laevis nucleotide binding protein 1 (xNubp1) is important for convergent extension movements and controls ciliogenesis via regulation of the actin cytoskeleton.Dev. Biol.380243–258. 10.1016/j.ydbio.2013.05.004
76
IzdebskaM.ZielińskaW.GrzankaD.GagatM. (2018). The role of actin dynamics and actin-binding proteins expression in epithelial-to-mesenchymal transition and its association with cancer progression and evaluation of possible therapeutic targets.Biomed. Res. Int.2018:4578373. 10.1155/2018/4578373
77
JanmeyP. A.HvidtS.OsterG. F.LambJ.StosselT. P.HartwigJ. H. (1990). Effect of ATP on actin filament stiffness.Nature34795–99. 10.1038/347095a0
78
JiangF.KuangB.QueY.LinZ.YuanL.XiaoW.et al (2016). The clinical significance of transforming acidic coiled-coil protein 3 expression in non-small cell lung cancer.Oncol. Rep.35436–446. 10.3892/or.2015.4373
79
JohnsonH. W.SchellM. J. (2009). Neuronal IP3 3-kinase is an F-actin-bundling protein: role in dendritic targeting and regulation of spine morphology.Mol. Biol. Cell.205166–5180. 10.1091/mbc.e09-01-0083
80
JurczykA.GromleyA.RedickS.San AgustinJ.WitmanG.PazourG. J.et al (2004). Pericentrin forms a complex with intraflagellar transport proteins and polycystin-2 and is required for primary cilia assembly.J. Cell Biol.166637–643. 10.1083/jcb.200405023
81
KabschW.MannherzH. G.SuckD.PaiE. F.HolmesK. C. (1990). Atomic structure of the actin:DNase I complex.Nature.34737–44. 10.1038/347037a0
82
KhaitlinaS. Y. (2014). Intracellular transport based on actin polymerization.Biochemistry79917–927. 10.1134/s0006297914090089
83
KhanN. A.WillemarckN.TalebiA.MarchandA.BindaM. M.DehairsJ.et al (2016). Identification of drugs that restore primary cilium expression in cancer cells.Oncotarget79975–9992. 10.18632/oncotarget.7198
84
KieselP.Alvarez ViarG.TsoyN.MaraspiniR.GorilakP.VargaV.et al (2020). The molecular structure of mammalian primary cilia revealed by cryo-electron tomography.Nat. Struct. Mol. Biol.10.1038/s41594-020-0507-4[Epub ahead of print].
85
KimJ.JoH.HongH.KimM. H.KimJ. M.LeeJ. K.et al (2015). Actin remodelling factors control ciliogenesis by regulating YAP/TAZ activity and vesicle trafficking.Nat. Commun.6:6781. 10.1038/ncomms7781
86
KimJ.LeeJ. E.HeynenS.SuyamaE.OnoK.LeeK. Y.et al (2010). Functional genomic screen for modulators of ciliogenesis and cilium length.Nature4641048–1051. 10.1038/nature08895
87
KimY. J.KimJ. (2019). Therapeutic perspectives for structural and functional abnormalities of cilia.Cell Mol. Life Sci.763695–3709. 10.1007/s00018-019-03158-6
88
KimY. J.KimS.JungY.JungE.KwonH. J.KimJ. (2018). Eupatilin rescues ciliary transition zone defects to ameliorate ciliopathy-related phenotypes.J. Clin. Invest.1283642–3648. 10.1172/jci99232
89
KohlhaseJ.WischermannA.ReichenbachH.FrosterU.EngelW. (1998). Mutations in the SALL1 putative transcription factor gene cause Townes-Brocks syndrome.Nat. Genet.1881–83. 10.1038/ng0198-81
90
KohliP.HöhneM.JüngstC.BertschS.EbertL. K.SchaussA. C.et al (2017). The ciliary membrane-associated proteome reveals actin-binding proteins as key components of cilia.EMBO Rep.181521–1535. 10.15252/embr.201643846
91
KulkarniS. S.GriffinJ. N.DateP. P.LiemK. F.Jr.KhokhaM. K. (2018). WDR5 stabilizes actin architecture to promote multiciliated cell formation.Dev. Cell46595–610.e3. 10.1016/j.devcel.2018.08.009
92
LauffartB.VaughanM. M.EddyR.ChervinskyD.DiCioccioR. A.BlackJ. D.et al (2005). Aberrations of TACC1 and TACC3 are associated with ovarian cancer.BMC Womens Health5:8. 10.1186/1472-6874-5-8
93
LazaridesE.WeberK. (1974). Actin antibody: the specific visualization of actin filaments in non-muscle cells.Proc. Natl. Acad. Sci. U.S.A.712268–2272. 10.1073/pnas.71.6.2268
94
LeeS.TanH. Y.GenevaI. I.KruglovA.CalvertP. D. (2018). Actin filaments partition primary cilia membranes into distinct fluid corrals.J. Cell Biol.2172831–2849. 10.1083/jcb.201711104
95
LemieuxM. G.JanzenD.HwangR.RoldanJ.JarchumI.KnechtD. A. (2014). Visualization of the actin cytoskeleton: different F-actin-binding probes tell different stories.Cytoskeleton (Hoboken)71157–169. 10.1002/cm.21160
96
LemosF. O.EhrlichB. E. (2018). Polycystin and calcium signaling in cell death and survival.Cell Calcium6937–45. 10.1016/j.ceca.2017.05.011
97
LiA.SaitoM.ChuangJ. Z.TsengY. Y.DedesmaC.TomizawaK.et al (2011). Ciliary transition zone activation of phosphorylated Tctex-1 controls ciliary resorption, S-phase entry and fate of neural progenitors.Nat. Cell Biol.13402–411. 10.1038/ncb2218
98
LodishH.BerkA.MatsudairaP.KaiserC. A.KriegerM.ScottM. P.et al (2000). Molecular Cell Biology.New York, NY: W. H. Freeman.
99
Loghman-AdhamM.NauliS. M.SotoC. E.KariukiB.ZhouJ. (2003). Immortalized epithelial cells from human autosomal dominant polycystic kidney cysts.Am. J. Physiol. Renal Physiol.285F397–F412. 10.1152/ajprenal.00310.2002
100
LopataA.HughesR.TiedeC.HeisslerS. M.SellersJ. R.KnightP. J.et al (2018). Affimer proteins for F-actin: novel affinity reagents that label F-actin in live and fixed cells.Sci. Rep.8:6572. 10.1038/s41598-018-24953-4
101
LukinavičiusG.ReymondL.D’EsteE.MasharinaA.GöttfertF.TaH.et al (2014). Fluorogenic probes for live-cell imaging of the cytoskeleton.Nat. Methods.11731–733. 10.1038/nmeth.2972
102
LukinavičiusG.UmezawaK.OlivierN.HonigmannA.YangG.PlassT.et al (2013). A near-infrared fluorophore for live-cell super-resolution microscopy of cellular proteins.Nat. Chem.5132–139. 10.1038/nchem.1546
103
LynenF.WielandU. (1938). Über die Giftstoffe des Knollenblätterpilzes. IV.Justus Liebigs Ann. Chem.53393–117. 10.1002/jlac.19385330105
104
MaciverS. K.PopeB. J.WhytockS.WeedsA. G. (1998). The effect of two actin depolymerizing factors (ADF/cofilins) on actin filament turnover: pH sensitivity of F-actin binding by human ADF, but not of Acanthamoeba actophorin.Eur. J. Biochem.256388–397. 10.1046/j.1432-1327.1998.2560388.x
105
MalickiJ. J.JohnsonC. A. (2017). The cilium: cellular antenna and central processing unit.Trends Cell Biol.27126–140. 10.1016/j.tcb.2016.08.002
106
MatthewsJ. B.SmithJ. A.HrnjezB. J. (1997). Effects of F-actin stabilization or disassembly on epithelial Cl- secretion and Na-K-2Cl cotransport.Am. J. Physiol.272C254–C262. 10.1152/ajpcell.1997.272.1.C254
107
MeijerE.GansevoortR. T.de JongP. E.van der WalA. M.LeonhardW. N.de KreyS. R.et al (2011). Therapeutic potential of vasopressin V2 receptor antagonist in a mouse model for autosomal dominant polycystic kidney disease: optimal timing and dosing of the drug.Nephrol. Dial. Transplant.262445–2453. 10.1093/ndt/gfr069
108
MelakM.PlessnerM.GrosseR. (2017). Actin visualization at a glance.J. Cell Sci.130525–530. 10.1242/jcs.189068
109
MenzlI.LebeauL.PandeyR.HassounahN. B.LiF. W.NagleR.et al (2014). Loss of primary cilia occurs early in breast cancer development.Cilia3:7. 10.1186/2046-2530-3-7
110
MickD. U.RodriguesR. B.LeibR. D.AdamsC. M.ChienA. S.GygiS. P.et al (2015). Proteomics of primary cilia by proximity labeling.Dev. Cell35497–512. 10.1016/j.devcel.2015.10.015
111
Miki-NoumuraT.OosawaF. (1969). An actin-like protein of the sea urchin eggs. I. Its interaction with myosin from rabbit striated muscle.Exp. Cell Res.56224–232. 10.1016/0014-4827(69)90006-8
112
MillerA. L. (2011). The contractile ring.Curr. Biol.21R976–R978. 10.1016/j.cub.2011.10.044
113
MirvisM.StearnsT.James NelsonW. (2018). Cilium structure, assembly, and disassembly regulated by the cytoskeleton.Biochem. J.4752329–2353. 10.1042/bcj20170453
114
MitchellB.JacobsR.LiJ.ChienS.KintnerC. (2007). A positive feedback mechanism governs the polarity and motion of motile cilia.Nature44797–101. 10.1038/nature05771
115
MiyamotoT.HosobaK.OchiaiH.RoybaE.IzumiH.SakumaT.et al (2015). The microtubule-depolymerizing activity of a mitotic kinesin protein KIF2A drives primary cilia disassembly coupled with cell proliferation.Cell Rep.10664–673. 10.1016/j.celrep.2015.01.003
116
MiyoshiK.OnishiK.AsanumaM.MiyazakiI.Diaz-CorralesF. J.OgawaN. (2006). Embryonic expression of pericentrin suggests universal roles in ciliogenesis.Dev. Genes Evol.216537–542. 10.1007/s00427-006-0065-8
117
MoldayR. S.MoritzO. L. (2015). Photoreceptors at a glance.J. Cell Sci.1284039–4045. 10.1242/jcs.175687
118
Molla-HermanA.GhossoubR.BlisnickT.MeunierA.SerresC.SilbermannF.et al (2010). The ciliary pocket: an endocytic membrane domain at the base of primary and motile cilia.J. Cell Sci.1231785–1795. 10.1242/jcs.059519
119
MortonW. M.AyscoughK. R.McLaughlinP. J. (2000). Latrunculin alters the actin-monomer subunit interface to prevent polymerization.Nat. Cell Biol.2376–378. 10.1038/35014075
120
MühlhansJ.BrandstätterJ. H.GiesslA. (2011). The centrosomal protein pericentrin identified at the basal body complex of the connecting cilium in mouse photoreceptors.PLoS One6:e26496. 10.1371/journal.pone.0026496
121
MullinsR. D.HeuserJ. A.PollardT. D. (1998). The interaction of Arp2/3 complex with actin: nucleation, high affinity pointed end capping, and formation of branching networks of filaments.Proc. Natl. Acad. Sci. U.S.A.956181–6186. 10.1073/pnas.95.11.6181
122
NagaiT.MizunoK. (2017). Jasplakinolide induces primary cilium formation through cell rounding and YAP inactivation.PLoS One12:e0183030. 10.1371/journal.pone.0183030
123
NagerA. R.GoldsteinJ. S.Herranz-PérezV.PortranD.YeF.Garcia-VerdugoJ. M.et al (2017). An actin network dispatches ciliary GPCRs into extracellular vesicles to modulate signaling.Cell168252–263.e14. 10.1016/j.cell.2016.11.036
124
NakamuraF.StosselT. P.HartwigJ. H. (2011). The filamins: organizers of cell structure and function.Cell Adh. Migr.5160–169. 10.4161/cam.5.2.14401
125
NishimuraD. Y.BayeL. M.PerveenR.SearbyC. C.Avila-FernandezA.PereiroI.et al (2010). Discovery and functional analysis of a retinitis pigmentosa gene, C2ORF71.Am. J. Hum. Genet.86686–695. 10.1016/j.ajhg.2010.03.005
126
NolenB. J.TomasevicN.RussellA.PierceD. W.JiaZ.McCormickC. D.et al (2009). Characterization of two classes of small molecule inhibitors of Arp2/3 complex.Nature4601031–1034. 10.1038/nature08231
127
PanD. (2010). The hippo signaling pathway in development and cancer.Dev. Cell19491–505. 10.1016/j.devcel.2010.09.011
128
PanJ.YouY.HuangT.BrodyS. L. (2007). RhoA-mediated apical actin enrichment is required for ciliogenesis and promoted by Foxj1.J. Cell Sci.1201868–1876. 10.1242/jcs.005306
129
PangK. M.LeeE.KnechtD. A. (1998). Use of a fusion protein between GFP and an actin-binding domain to visualize transient filamentous-actin structures.Curr. Biol.8405–408. 10.1016/s0960-9822(98)70159-9
130
PanzaP.MaierJ.SchmeesC.RothbauerU.SöllnerC. (2015). Live imaging of endogenous protein dynamics in zebrafish using chromobodies.Development1421879–1884. 10.1242/dev.118943
131
ParkT. J.HaigoS. L.WallingfordJ. B. (2006). Ciliogenesis defects in embryos lacking inturned or fuzzy function are associated with failure of planar cell polarity and Hedgehog signaling.Nat. Genet.38303–311. 10.1038/ng1753
132
ParkT. J.MitchellB. J.AbituaP. B.KintnerC.WallingfordJ. B. (2008). Dishevelled controls apical docking and planar polarization of basal bodies in ciliated epithelial cells.Nat. Genet.40871–879. 10.1038/ng.104
133
ParriniE.RamazzottiA.DobynsW. B.MeiD.MoroF.VeggiottiP.et al (2006). Periventricular heterotopia: phenotypic heterogeneity and correlation with Filamin A mutations.Brain1291892–1906. 10.1093/brain/awl125
134
PerrinB. J.ErvastiJ. M. (2010). The actin gene family: function follows isoform.Cytoskeleton (Hoboken)67630–634. 10.1002/cm.20475
135
PetersonJ. R.BickfordL. C.MorganD.KimA. S.OuerfelliO.KirschnerM. W.et al (2004). Chemical inhibition of N-WASP by stabilization of a native autoinhibited conformation.Nat. Struct. Mol. Biol.11747–755. 10.1038/nsmb796
136
PhuaS. C.ChibaS.SuzukiM.SuE.RobersonE. C.PusapatiG. V.et al (2017). Dynamic remodeling of membrane composition drives cell cycle through primary cilia excision.Cell168264–279.e15. 10.1016/j.cell.2016.12.032
137
PianoI.NovelliE.GascoP.GhidoniR.StrettoiE.GarginiC. (2013). Cone survival and preservation of visual acuity in an animal model of retinal degeneration.Eur. J. Neurosci.371853–1862. 10.1111/ejn.12196
138
PiccoloS.DupontS.CordenonsiM. (2014). The biology of YAP/TAZ: hippo signaling and beyond.Physiol. Rev.941287–1312. 10.1152/physrev.00005.2014
139
PollardT. D.BlanchoinL.MullinsR. D. (2000). Molecular mechanisms controlling actin filament dynamics in nonmuscle cells.Annu. Rev. Biophys. Biomol. Struct.29545–576. 10.1146/annurev.biophys.29.1.545
140
PugachevaE. N.JablonskiS. A.HartmanT. R.HenskeE. P.GolemisE. A. (2007). HEF1-dependent Aurora A activation induces disassembly of the primary cilium.Cell1291351–1363. 10.1016/j.cell.2007.04.035
141
QieY.WangL.DuE.ChenS.LuC.DingN.et al (2020). TACC3 promotes prostate cancer cell proliferation and restrains primary cilium formation.Exp. Cell Res.390:111952. 10.1016/j.yexcr.2020.111952
142
RajgorD.ShanahanC. M. (2013). Nesprins: from the nuclear envelope and beyond.Expert Rev. Mol. Med.15:e5. 10.1017/erm.2013.6
143
RaoY.HaoR.WangB.YaoT. P. (2014). A Mec17-Myosin II effector axis coordinates microtubule acetylation and actin dynamics to control primary cilium biogenesis.PLoS One9:e114087. 10.1371/journal.pone.0114087
144
ReiterJ. F.LerouxM. R. (2017). Genes and molecular pathways underpinning ciliopathies.Nat. Rev. Mol. Cell Biol.18533–547. 10.1038/nrm.2017.60
145
RidleyA. J.HallA. (1992). The small GTP-binding protein rho regulates the assembly of focal adhesions and actin stress fibers in response to growth factors.Cell70389–399. 10.1016/0092-8674(92)90163-7
146
RiedlJ.CrevennaA. H.KessenbrockK.YuJ. H.NeukirchenD.BistaM.et al (2008). Lifeact: a versatile marker to visualize F-actin.Nat. Methods5605–607. 10.1038/nmeth.1220
147
RocchettiA.HawesC.KriechbaumerV. (2014). Fluorescent labelling of the actin cytoskeleton in plants using a cameloid antibody.Plant Methods10:12. 10.1186/1746-4811-10-12
148
RossA. J.May-SimeraH.EichersE. R.KaiM.HillJ.JaggerD. J.et al (2005). Disruption of Bardet-Biedl syndrome ciliary proteins perturbs planar cell polarity in vertebrates.Nat. Genet.371135–1140. 10.1038/ng1644
149
RossettiL.GiaccariA.Klein-RobbenhaarE.VogelL. R. (1990). Insulinomimetic properties of trace elements and characterization of their in vivo mode of action.Diabetes391243–1250. 10.2337/diab.39.10.1243
150
RothbauerU.ZolghadrK.TillibS.NowakD.SchermellehL.GahlA.et al (2006). Targeting and tracing antigens in live cells with fluorescent nanobodies.Nat. Methods3887–889. 10.1038/nmeth953
151
SaitoM.OtsuW.HsuK. S.ChuangJ. Z.YanagisawaT.ShiehV.et al (2017). Tctex-1 controls ciliary resorption by regulating branched actin polymerization and endocytosis.EMBO Rep.181460–1472. 10.15252/embr.201744204
152
SaitohM.IshikawaT.MatsushimaS.NakaM.HidakaH. (1987). Selective inhibition of catalytic activity of smooth muscle myosin light chain kinase.J. Biol. Chem.2627796–7801.
153
SchoenenbergerC. A.MannherzH. G.JockuschB. M. (2011). Actin: from structural plasticity to functional diversity.Eur. J. Cell Biol.90797–804. 10.1016/j.ejcb.2011.05.002
154
SchramlP.FrewI. J.ThomaC. R.BoysenG.StruckmannK.KrekW.et al (2009). Sporadic clear cell renal cell carcinoma but not the papillary type is characterized by severely reduced frequency of primary cilia.Mod. Pathol.2231–36. 10.1038/modpathol.2008.132
155
SchuhM. (2011). An actin-dependent mechanism for long-range vesicle transport.Nat. Cell Biol.131431–1436. 10.1038/ncb2353
156
SchwartzE. A.LeonardM. L.BiziosR.BowserS. S. (1997). Analysis and modeling of the primary cilium bending response to fluid shear.Am. J. Physiol.272F132–F138. 10.1152/ajprenal.1997.272.1.F132
157
SedzinskiJ.HannezoE.TuF.BiroM.WallingfordJ. B. (2016). Emergence of an apical epithelial cell surface in vivo.Dev. Cell3624–35. 10.1016/j.devcel.2015.12.013
158
SedzinskiJ.HannezoE.TuF.BiroM.WallingfordJ. B. (2017). RhoA regulates actin network dynamics during apical surface emergence in multiciliated epithelial cells.J. Cell Sci.130420–428. 10.1242/jcs.194704
159
SharmaN.KosanZ. A.StallworthJ. E.BerbariN. F.YoderB. K. (2011). Soluble levels of cytosolic tubulin regulate ciliary length control.Mol. Biol. Cell22806–816. 10.1091/mbc.E10-03-0269
160
SorokinS. P. (1968). Reconstructions of centriole formation and ciliogenesis in mammalian lungs.J. Cell Sci.3207–230.
161
SpectorI.ShochetN. R.BlasbergerD.KashmanY. (1989). Latrunculins–novel marine macrolides that disrupt microfilament organization and affect cell growth: I. Comparison with cytochalasin D.Cell Motil. Cytoskeleton13127–144. 10.1002/cm.970130302
162
SpectorI.ShochetN. R.KashmanY.GroweissA. (1983). Latrunculins: novel marine toxins that disrupt microfilament organization in cultured cells.Science219493–495. 10.1126/science.6681676
163
SpracklenA. J.FaganT. N.LovanderK. E.TootleT. L. (2014). The pros and cons of common actin labeling tools for visualizing actin dynamics during Drosophila oogenesis.Dev. Biol.393209–226. 10.1016/j.ydbio.2014.06.022
164
StewartK.GaitanY.ShaferM. E.AoudjitL.HuD.SharmaR.et al (2016). A point mutation in p190A RhoGAP affects ciliogenesis and leads to glomerulocystic kidney defects.PLoS Genet.12:e1005785. 10.1371/journal.pgen.1005785
165
StraightA. F.CheungA.LimouzeJ.ChenI.WestwoodN. J.SellersJ. R.et al (2003). Dissecting temporal and spatial control of cytokinesis with a myosin II Inhibitor.Science2991743–1747. 10.1126/science.1081412
166
StraubF. B. (1942). Actin.Stud. Inst. of Med. Chem.23–15.
167
StraubF. B. (1943). Actin, II.Stud. Inst. of Med. Chem.323–37.
168
StreetsA. J.ProssedaP. P.OngA. C. (2020). Polycystin-1 regulates ARHGAP35-dependent centrosomal RhoA activation and ROCK signalling.JCI Insight5:e135385. 10.1172/jci.insight.135385
169
StubbsJ. L.OishiI.Izpisúa BelmonteJ. C.KintnerC. (2008). The forkhead protein Foxj1 specifies node-like cilia in Xenopus and zebrafish embryos.Nat. Genet.401454–1460. 10.1038/ng.267
170
SuarezC.RolandJ.Boujemaa-PaterskiR.KangH.McCulloughB. R.ReymannA. C.et al (2011). Cofilin tunes the nucleotide state of actin filaments and severs at bare and decorated segment boundaries.Curr. Biol.21862–868. 10.1016/j.cub.2011.03.064
171
TakasatoM.LittleM. H. (2017). Making a kidney organoid using the directed differentiation of human pluripotent stem cells.Methods Mol. Biol.1597195–206. 10.1007/978-1-4939-6949-4_14
172
TobinJ. L.BealesP. L. (2009). The nonmotile ciliopathies.Genet. Med.11386–402. 10.1097/GIM.0b013e3181a02882
173
TojkanderS.GatevaG.LappalainenP. (2012). Actin stress fibers–assembly, dynamics and biological roles.J. Cell Sci.1251855–1864. 10.1242/jcs.098087
174
TorresV. E.ChapmanA. B.DevuystO.GansevoortR. T.GranthamJ. J.HigashiharaE.et al (2012). Tolvaptan in patients with autosomal dominant polycystic kidney disease.N. Engl. J. Med.3672407–2418. 10.1056/NEJMoa1205511
175
TorresV. E.ChapmanA. B.DevuystO.GansevoortR. T.PerroneR. D.KochG.et al (2017). Tolvaptan in later-stage autosomal dominant polycystic kidney disease.N. Engl. J. Med.3771930–1942. 10.1056/NEJMoa1710030
176
ValenteE. M.LoganC. V.Mougou-ZerelliS.LeeJ. H.SilhavyJ. L.BrancatiF.et al (2010). Mutations in TMEM216 perturb ciliogenesis and cause Joubert, Meckel and related syndromes.Nat. Genet.42619–625. 10.1038/ng.594
177
VarlandS.VandekerckhoveJ.DrazicA. (2019). Actin post-translational modifications: the cinderella of cytoskeletal control.Trends Biochem. Sci.44502–516. 10.1016/j.tibs.2018.11.010
178
Vicente-ManzanaresM.MaX.AdelsteinR. S.HorwitzA. R. (2009). Non-muscle myosin II takes centre stage in cell adhesion and migration.Nat. Rev. Mol. Cell Biol.10778–790. 10.1038/nrm2786
179
VisegrádyB.LorinczyD.HildG.SomogyiB.NyitraiM. (2005). A simple model for the cooperative stabilisation of actin filaments by phalloidin and jasplakinolide.FEBS Lett.5796–10. 10.1016/j.febslet.2004.11.023
180
WadeE. M.HallidayB. J.JenkinsZ. A.O’NeillA. C.RobertsonS. P. (2020). The X-linked filaminopathies: synergistic insights from clinical and molecular analysis.Hum. Mutat.41865–883. 10.1002/humu.24002
181
WangJ.NakamuraF. (2019). Identification of filamin A mechanobinding partner II: fimbacin is a novel actin cross-linking and Filamin A binding protein.Biochemistry584737–4743. 10.1021/acs.biochem.9b00101
182
WangX.WuY.WardC. J.HarrisP. C.TorresV. E. (2008). Vasopressin directly regulates cyst growth in polycystic kidney disease.J. Am. Soc. Nephrol.19102–108. 10.1681/asn.2007060688
183
WangY.DavidowL.ArvanitesA. C.BlanchardJ.LamK.XuK.et al (2012). Glucocorticoid compounds modify smoothened localization and hedgehog pathway activity.Chem. Biol.19972–982. 10.1016/j.chembiol.2012.06.012
184
WatersA. M.BealesP. L. (2011). Ciliopathies: an expanding disease spectrum.Pediatr. Nephrol.261039–1056. 10.1007/s00467-010-1731-7
185
WegnerA. (1982). Treadmilling of actin at physiological salt concentrations. An analysis of the critical concentrations of actin filaments.J. Mol. Biol.161607–615. 10.1016/0022-2836(82)90411-9
186
WehlandJ.OsbornM.WeberK. (1977). Phalloidin-induced actin polymerization in the cytoplasm of cultured cells interferes with cell locomotion and growth.Proc. Natl. Acad. Sci. U.S.A.745613–5617. 10.1073/pnas.74.12.5613
187
WernerM. E.HwangP.HuismanF.TaborekP.YuC. C.MitchellB. J. (2011). Actin and microtubules drive differential aspects of planar cell polarity in multiciliated cells.J. Cell Biol.19519–26. 10.1083/jcb.201106110
188
WhewayG.LordJ.BaralleD. (2019). Splicing in the pathogenesis, diagnosis and treatment of ciliopathies.Biochim. Biophys. Acta Gene Regul. Mech.1862:194433. 10.1016/j.bbagrm.2019.194433
189
WhewayG.SchmidtsM.MansD. A.SzymanskaK.NguyenT. T.RacherH.et al (2015). An siRNA-based functional genomics screen for the identification of regulators of ciliogenesis and ciliopathy genes.Nat. Cell Biol.171074–1087. 10.1038/ncb3201
190
WielandT. (1977). Modification of actins by phallotoxins.Naturwissenschaften64303–309. 10.1007/bf00446784
191
WilleyC. J.BlaisJ. D.HallA. K.KrasaH. B.MakinA. J.CzerwiecF. S. (2017). Prevalence of autosomal dominant polycystic kidney disease in the European Union.Nephrol. Dial. Transplant.321356–1363. 10.1093/ndt/gfw240
192
YamadaS.PokuttaS.DreesF.WeisW. I.NelsonW. J. (2005). Deconstructing the cadherin-catenin-actin complex.Cell123889–901. 10.1016/j.cell.2005.09.020
193
YanagidaT.NakaseM.NishiyamaK.OosawaF. (1984). Direct observation of motion of single F-actin filaments in the presence of myosin.Nature30758–60. 10.1038/307058a0
194
YeyatiP. L.SchillerR.MaliG.KasioulisI.KawamuraA.AdamsI. R.et al (2017). KDM3A coordinates actin dynamics with intraflagellar transport to regulate cilia stability.J. Cell Biol.216999–1013. 10.1083/jcb.201607032
195
YoungR. W. (1967). The renewal of photoreceptor cell outer segments.J. Cell Biol.3361–72. 10.1083/jcb.33.1.61
196
YoungR. W.BokD. (1969). Participation of the retinal pigment epithelium in the rod outer segment renewal process.J. Cell Biol.42392–403. 10.1083/jcb.42.2.392
197
ZhenY. Y.LibotteT.MunckM.NoegelA. A.KorenbaumE. (2002). NUANCE, a giant protein connecting the nucleus and actin cytoskeleton.J. Cell Sci.1153207–3222.
198
ZigmondS. H. (1993). Recent quantitative studies of actin filament turnover during cell locomotion.Cell Motil. Cytoskeleton25309–316. 10.1002/cm.970250402
199
ZimmermanW. C.SillibourneJ.RosaJ.DoxseyS. J. (2004). Mitosis-specific anchoring of gamma tubulin complexes by pericentrin controls spindle organization and mitotic entry.Mol. Biol. Cell.153642–3657. 10.1091/mbc.e03-11-0796
Summary
Keywords
drug screen, ROCK inhibitors, ciliopathies, polycystic kidney disease, ciliogenesis, actin cytoskeleton, cilia, cytoskeletal drugs
Citation
Smith CEL, Lake AVR and Johnson CA (2020) Primary Cilia, Ciliogenesis and the Actin Cytoskeleton: A Little Less Resorption, A Little More Actin Please. Front. Cell Dev. Biol. 8:622822. doi: 10.3389/fcell.2020.622822
Received
29 October 2020
Accepted
24 November 2020
Published
17 December 2020
Volume
8 - 2020
Edited by
Helena Soares, Universidade de Lisboa, Portugal
Reviewed by
Tina Beyer, University Hospital Tübingen, Germany; Tatsuo Miyamoto, Hiroshima University, Japan
Updates

Check for updates
Copyright
© 2020 Smith, Lake and Johnson.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Colin A. Johnson, c.johnson@leeds.ac.uk
This article was submitted to Cell Adhesion and Migration, a section of the journal Frontiers in Cell and Developmental Biology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.